Regarding the Holding of the 42nd Expert Committee on the Provision of Anonymized Medical Information, etc.

News Highlights

The 42nd Expert Committee on the Provision of Anonymized Medical Information, etc. was held. This committee provides expert opinions on the handling of anonymized processed information in the medical field, and it is presumed that discussions were held to promote the utilization of information held by medical institutions. In the context of medical M&A and business succession, key discussion points include the value of choosing third-party succession over closure or廃業 (haigyō – business closure/liquidation) as a measure to address successor issues, the importance of early preparation by chairpersons/directors/principals starting around age 60 with a 5-10 year timeframe, and the utilization of support organizations specializing in the medical industry.

M&A Medical Editorial Department’s Perspective

The convening of this expert committee not only promotes the utilization of medical information but also suggests potential solutions for the business succession issues faced by medical institutions. In particular, the recommendation for chairpersons/directors/principals to prepare with a 5-10 year timeframe starting around age 60 can be interpreted as a message that, prior to considering closure or 廃業 (haigyō – business closure/liquidation), the possibility of “business continuity” through third-party succession should be considered early on, addressing the lack of successors that many medical institutions face. As the utilization of medical data as anonymized processed information advances, it could lead to increased efficiency in M&A due diligence and improved accuracy in business valuation. The use of advisors specialized in the medical industry will be an indispensable element in smoothly advancing such complex schemes.

Discussion Points Indicated by This News

• The potential for medical data utilization as anonymized processed information to create new added value in business succession.
• Business succession preparation with a 5-10 year timeframe starting around age 60 makes third-party succession a realistic option.
• Advancements in medical information utilization contribute to improved accuracy in M&A due diligence and business valuation.
• Discussions at the expert committee may promote the development of an environment for the business continuity of medical institutions.

Practical Questions Arising from This News

• What are the specific merits and demerits of providing medical data as anonymized processed information?
• What specific support can medical institution-specialized advisors provide when considering third-party succession?
• In a situation with a lack of successors, when is the optimal time to start considering options other than closure or business closure/liquidation?

If You Feel “Should I Consult Too?”

Is your institution’s chairperson/director/principal around 60 years old and vaguely concerned about successor issues? Before facing the option of “closure” or “廃業 (haigyō – business closure/liquidation)”, it may be time to explore possibilities for continuing and developing the business, such as utilizing medical data as anonymized processed information or pursuing third-party succession. Based on the discussions at the expert committee, we recommend consulting with medical M&A specialists early on to concretely envision your institution’s future.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution, with a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here